Introducing a fundamentally new approach to adult stem cells and medicine.
Fate Therapeutics was founded by the world’s leading experts in adult stem cell biology to develop and commercialize therapies to control the destiny of cells.
The company’s revolutionary platforms are focused on developing medicines that awaken adult stem cells resident within the body to fight disease and regenerate damaged cells and tissue, and on the use of small molecules to reprogram mature adult cells to an embryonic-like state.
Fate’s work has broad application, and offers new hope in the treatment of degenerative diseases, developmental disorders, and cancer and in enabling the creation of patient-identical cells for transplantation. |
|
"Fate’s approach is the dawn of a new day in medicine." -- Dr. Ben Shapiro, retired Executive Vice President of Worldwide Basic Research, Merck Research Laboratories
Top researchers from Harvard University, Stanford University, University of Washington, and Scripps Research Institute, together with four of the leading life sciences venture firms in the country, declare a revolution in adult stem cell medicines.
Advances in stem cell research have shifted the entire debate. Science is proving that adult stem cell proliferation and differentiation can be modulated in the human body, and now has the ability to induce pluripotent stem cells from adult human tissue rather than relying on the use of stem cells derived from embryos.
|
|
|
Our Team
Introducing Fate's world class research team
 Partners
Fate investors share a market changing vision
 Breakthroughs
Discoveries in adult stem cell research
|
|
